The presence of additional thrombophilic risk factors is strongly associated with thrombotic events in patients with Antiphospholipid antibodies.

被引：0
|
作者：
Miesbach, W [1 ]
Boehm, M [1 ]
Asmelash, G [1 ]
Scharrer, I [1 ]
机构：
[1] Univ Frankfurt, D-6000 Frankfurt, Germany
来源：
BLOOD | 2003年 / 102卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
4169
引用
收藏
页码：115B / 115B
页数：1
相关论文
共 50 条
  • [1] Thrombophilic patients with migraines have a high incidence of antiphospholipid antibodies.
    Zeigler, ZR
    Hassett, ALC
    BLOOD, 2005, 106 (11) : 113B - 113B
  • [2] The platelet glycoprotein IIIA polymorphism PIA2 and risk of thrombotic events in patients with antiphospholipid antibodies.
    Sobel, RE
    Bray, PF
    Richardson, C
    Petri, M
    Salmon, JE
    ARTHRITIS AND RHEUMATISM, 1998, 41 (09): : S172 - S172
  • [3] Prothrombotic change in inflammation-inducible coagulation factors identifies thrombotic risk in SLE patients with antiphospholipid antibodies.
    Andersen, JC
    Sagar, H
    Syed, M
    Haggood, AS
    Patricia, D
    BLOOD, 2003, 102 (11) : 120B - 120B
  • [4] Infections associated to severe thrombotic events and antiphospholipid antibodies
    Vidal, M
    Corbin, V
    Chanet, V
    Ruivard, M
    Gourdon, F
    Laurichesse, H
    Beytout, J
    Lesens, O
    MEDECINE ET MALADIES INFECTIEUSES, 2005, 35 (11): : 552 - 555
  • [5] Presence of antiphospholipid antibody is a risk factor in thrombotic events in patients with antiphospholipid syndrome or relevant diseases
    Koji Habe
    Hideo Wada
    Takeshi Matsumoto
    Kohshi Ohishi
    Makoto Ikejiri
    Kimiko Matsubara
    Tatsuhiko Morioka
    Yuki Kamimoto
    Tomoaki Ikeda
    Naoyuki Katayama
    Tsutomu Nobori
    Hitoshi Mizutani
    International Journal of Hematology, 2013, 97 : 345 - 350
  • [6] Presence of antiphospholipid antibody is a risk factor in thrombotic events in patients with antiphospholipid syndrome or relevant diseases
    Habe, Koji
    Wada, Hideo
    Matsumoto, Takeshi
    Ohishi, Kohshi
    Ikejiri, Makoto
    Matsubara, Kimiko
    Morioka, Tatsuhiko
    Kamimoto, Yuki
    Ikeda, Tomoaki
    Katayama, Naoyuki
    Nobori, Tsutomu
    Mizutani, Hitoshi
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2013, 97 (03) : 345 - 350
  • [7] Presence of Antiphospholipid Antibodies as a Risk Factor for Thrombotic Events in Patients with Connective Tissue Diseases and Idiopathic Thrombocytopenic Purpura
    Habe, Koji
    Wada, Hideo
    Matsumoto, Takeshi
    Ohishi, Kohshi
    Ikejiri, Makoto
    Matsubara, Kimiko
    Morioka, Tatsuhiko
    Kamimoto, Yuki
    Ikeda, Tomoaki
    Katayama, Naoyuki
    Mizutani, Hitoshi
    INTERNAL MEDICINE, 2016, 55 (06) : 589 - 595
  • [8] Dissecting the Thrombotic Events in the Presence of Antiphospholipid Antibodies in COVID-19 Spanish Patients
    Geraldine Rita, Claudia
    Iturrieta-Zuazo, Ignacio
    Pariente-Rodriguez, Roberto
    Tejeda-Velarde, Amalie
    Nieto-Ganan, Israel
    Carrasco-Sayalero, Angela
    EURASIAN JOURNAL OF MEDICINE AND ONCOLOGY, 2021, 5 (02): : 195 - 199
  • [9] Risk factors associated with thrombosis in patients with antiphospholipid antibodies
    Hansen, KE
    Kong, DF
    Moore, KD
    Ortel, TL
    JOURNAL OF RHEUMATOLOGY, 2001, 28 (09) : 2018 - 2024
  • [10] Impact of antiphospholipid antibodies on thrombotic events in ambulatory cancer patients
    Kansuttiviwat, Chalermkiat
    Niprapan, Piangrawee
    Tantiworawit, Adisak
    Norasetthada, Lalita
    Rattarittamrong, Ekarat
    Rattanathammethee, Thanawat
    Hantrakool, Sasinee
    Piriyakhuntorn, Pokpong
    Punnachet, Teerachat
    Hantrakun, Nonthakorn
    Chai-Adisaksopha, Chatree
    PLOS ONE, 2023, 18 (01):
12345